Primary prevention lipid-lowering drug therapy

Circulation. 2002 Aug 13;106(7):e35-6; author reply e35-6. doi: 10.1161/01.cir.0000025828.88749.55.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control*
  • Clinical Trials as Topic
  • Female
  • Humans
  • Hypolipidemic Agents / pharmacology*
  • Male
  • Middle Aged
  • Patient Selection
  • Prevalence
  • Risk Assessment
  • Risk Factors
  • Sample Size
  • Sex Factors

Substances

  • Hypolipidemic Agents